(Sigma), lynestrenol (Prestwick Chemicals), mevinolin (Sigma), mitoxantrone dihydrochloride (Sigma), nitrofurantoin (Sigma), sertraline (Sigma), suloctidil (Sigma), tamoxifen citrate (Sigma), trifluoperazine dihydrochloride and zaprinast (Sigma) were purchased as standard powders. All stock solutions were prepared in 100% dimethyl sulfoxide (DMSO) to a final concentration of 12.8 mg/mL with the exception of daunorubicin HCl, terbinafine, trifluoroperazine dihydrochloride and ellipticine, which had a final concentration of 6.4 mg/mL.
Fluconazole was maintained at room temperature, all other stock solutions were stored at -20°C.
Data analysis of Prestwick library screen
For each plate, 32 high growth controls and 12 low growth controls were used to establish a Z' score for each screen. Assay absorbance values were corrected using these controls and converted to percent residual activity. Replicate plots were performed on the duplicates to assess the reproducibility of the screens. Residual activity data was then averaged between the duplicate screens. Bias in the screening data was removed by normalizing the data plate-wise ( Figure S1 ).
The diagonal (y=x) was used to identify hits from the screen data with versus without fluconazole. Compounds that were more than 2 median absolute deviations (MADs) below the diagonal were defined as hits.
Genome-wide deletion strain sensitivity profiles
Deletion pools were generated by growing up the collections on XY glucose plates (YEPD +100 mg/L adenine and 200 mg/L tryptophan) containing 200 mg/L G418. Colonies were grown for 2 days and then condensed (384 format) onto XY agar plates and grown for another 2 days. Cells were then scraped into 15% glycerol, aliquots of the deletion pools were stored at -80°C.
For each of the drugs (trifluoperazine, clomiphene, sertraline, tamoxifen, suloctidil, Lcycloserine), concentrations that cause up to ~30% growth inhibition were determined. A 5x5 matrix of increasing concentrations of each drug (concentrations that cause less than 25% growth inhibition) and fluconazole (0-8 μg/mL, corresponding to 0-25% growth inhibition) was prepared in 10 mL cultures as well as single drug cultures with up to 30% growth inhibition, and solventonly controls (DMSO and water).
Data analysis of barcode arrays
Identification of sensitive and resistant deletion strains was performed with custom R scripts and the limma, gplots, DBI and RMySQL packages for R. Low intensity and low quality spots were excluded from further analysis. Intensities of duplicate spots were averaged and log2 fold change ratios (drug treated/DMSO control) were used to calculate Z-scores for up and down barcode tags: Z= (x-μ)/σ with μ the mean log2 fold change for the whole array and σ the standard deviation. These two scores were then averaged for each deletion strain to give the final Z-score.
In vivo imaging of effects of syncretic compounds
Concentrations of drugs required to inhibit cell growth for microscopy studies were determined using a higher inoculum than described for determining standard MIC values in order to provide a sufficient number of cells for analysis. Growth in MIC assay plates was monitored spectrophotometrically for at least 24 h. Drug concentrations that produced a significant decrease in cell growth were selected for imaging. Overnight cultures of S. cerevisiae BY4741 were diluted to OD 600 of 2.4, then further diluted 1/20 in SC media. Drugs were added at mid-log phase and cells harvested for staining after 30-60 min of incubation. Hoechst dye (Bisbenzimide H 33258, Sigma#B2883) was prepared as a 20 mM stock solution in distilled water. Cells were harvested by centrifugation at 12,000 rpm for 2 min, and resuspended in 40 μL of YPD and 10 μL of 200 μM Hoechst. Cells were incubated with stain at 30°C for 15 min, washed once with dH 2 O and resuspended in 15 μL of dH 2 O for slide mounting. Calcofluor White M2R (Fluorescent Brightener 28, Sigma#F3543) was dissolved in distilled water to a working concentration of 3.5 mg/mL with the addition of 1 drop of 5 M NaOH to aid in solubility. Cells were harvested by centrifugation and resuspended in 198 μL of 0.1 M Tris/HCl, pH 8 to which 2 μL of prepared Calcofluor White M2R was added. Cells were incubated with stain at 30°C for 15 min, washed with dH 2 O, resuspended in 15 μL of dH 2 O and mounted. Mitotracker Green FM (Molecular Probes #M7514) was dissolved to a 1 mM stock solution in DMSO. Stain was added to YPD to a final concentration of 500 nM and warmed to 30°C. Cells were harvested and resuspended in the prewarmed media plus Mitrotracker Green FM, incubated at 30°C for 45 min with shaking, then washed with 200 μL PBS, resuspended in 15 μL of dH 2 O and mounted. FM4-64 (N-(3-triethylammoniumpropyl)-4-(6-(4-(diethylamino)phenyl)hexatrienyl)pyridinium dibromide) (Molecular Probes#T13320) was dissolved to a working stock solution of 1 mg/mL with DMSO. Cells were harvested by centrifugation and resuspended in 40L of YPD with 1 μL of 1 mg/mL stock solution of FM4-64. Cells were incubated at 30°C for 15 min, centrifuged, resuspended in 15 μl PBS and mounted.
Insect larvae inoculation and injection
C. neoformans H99 inocula used for injections were standardized as follows. Overnight cultures grown at 30°C were centrifuged, rinsed and diluted to an OD 530 of 1.3 in sterile PBS. A 10 μL aliquot of this inoculum contained 8 x 10 3 cfu. Caterpillars were injected with 10 μL of the Cryptococcus preparation using a 250 μL barrel volume Hamilton luer lok syringe, a 30 gauge needle and a Hamilton repeating dispenser. Cryptococcus was injected in the lowest left abdominal proleg of each worm. Infected caterpillars were incubated in a dedicated incubator for 24 h at 37°C prior to injection of compound, fluconazole, combinations and/or DMSO and PBS controls. Sets of caterpillars were also injected with sterile PBS in place of Cryptococcus to observe the effects of the saline buffer alone on survival rate. Uninjected controls were also observed to ensure that injection did not affect mortality.
A concentration of 1 μg fluconazole in saline/worm resulted in a sub-MIC pattern of mortality over 7 days, mirroring that of the Cryptococcus-alone controls. Suloctidil, sertraline, tamoxifen citrate, trifluoperazine dihydrochloride and fenpropidin were administered as injections of 25.6 μg/worm, alone and in combination with fluconazole. Caterpillars were then examined visually over a 1 week period for discoloration due to melanization and for failure to respond to touch as 
Supplementary data files
Dataset_HaploidTransformedData -Z-scores from chemical-genetic profiles of single drugs (syncretic synergizers and fluconazole) as well as drug combinations with fluconazole.
Concentrations are provided in the column name for each screen. 4820 haploid deletions strains were screened.
Dataset_HetEssTransformedData -Sensitivity Z-scores of 1101 heterozygous essential deletion strains to five of the syncretic drugs and fluconazole, as assessed by barcode microarray hybridization. Concentrations were as follows: trifluoperazine 2.25 μg/mL, tamoxifen 1 μg/mL, L-cycloserine 60 μg/mL, sertraline 1.2 μg/mL and clomiphene 0.8 μg/mL. Two screens were performed for fluconazole, one at 8 μg/mL and one at 10 μg/mL. Table S3 -Fractional inhibitory concentration index of hit compounds in each fungal species.
Supplementary tables
Values are given in μg/mL. YLL044W   MNN11   DLS1   RPA14   BUD26   IKI3   ERD1   VPS75   YPL056C   GDA1   FZO1   ALF1   NCS6   DPB4   URM1   YND1   UPF3   RHO4   SDS3   SFP1   YBL065W   YOR199W   MCM21   QDR2   RPL7A   SMF2   RAI1   MRPS18   RFC3   YGL072C   VPS52   MRT4   VMA22   YDR193W   MUM2   PRO1   LSM6   HSV2 YAL043C-A The combination treatment shows localization patterns similar to the tamoxifen treated cells with loss of cell membrane integrity, no intact vacuole and intense fluorescent signal because the dye was able to enter the cell more readily. Exposure times for row (i) were, from left to right, 2 seconds, 2 seconds, 100 milliseconds, 100 miliseconds. For row (iii) they were, from left to right, 8 seconds, 4 seconds, 180 milliseconds, and 180 milliseconds. The exposure times in rows (i) and (iiI) had to be greatly reduced with tamoxifen treatment to obtain an image that was not overexposed. The combination treatment shows localization patterns similar to the trifluoperazine-treated cells with loss of cell membrane integrity, no intact vacuole and intense fluorescent signal because the dye was able to enter the cell more readily. Exposure times for row (iii) were, from left to right, 2 seconds, 1 second, 100 milliseconds, 100 milliseconds, 100 milliseconds. Exposure times for rows (i) and (iii) had to be reduced with trifluoperazine treatment to obtain an image that was not overexposed.
L-cycloserine
(ii) (iii) Solvent control Fluconazole 64ug/mL Trifluoperazine 128ug/mL Trifluoperazine 256ug/mL Fluconazole 64ug/mL + Trifluoperazine 128ug/mL Figure S8C -Images of wild type S. cerevisiae treated with either no drug, fluconazole (64 g/mL), trifluoperazine (128 g/mL and 256 g/mL), or a combination of fluconazole (64 ìg/mL) and trifluoperazine (128 ìg/mL). The fluorescent dyes used were: (i) Calcofluor White M2R, (ii) FM4-64, and (iii) Mitrotracker Green FM. Exposure times for row (iii) were, from left to right, 2 seconds, 1 second, 100 milliseconds, 100 milliseconds, 100 milliseconds. Exposure times for rows (i) and (iii) were reduced for trifluoperazine-treated samples to obtain images that were not overexposed. 
